Welcome to CSNpharm! For Research Use Only!

MitoNEET, a target of the type II diabetes drug pioglitazone, is a key regulator of energy metabolism in mitochondria. MitoNEET is anchored to the mitochondrial outer membrane via its N-terminal α helix domain and hosts a redox-active [2Fe-2S] cluster in its C-terminal cytosolic region.

mitoNEET

Cat. No. Product Name CAS No. Information
CSN25313 NL-1 188532-26-5 NL-1 is a mitoNEET inhibitor with antileukemic effect. NL-1 inhibits REH and REH/Ara-C cells growth with IC50s of 47.35 µM and 56.26 µM, respectively.
<< PREV 1 NEXT >>